Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by EbbFlow88on Jan 16, 2023 11:22am
135 Views
Post# 35225673

RE:RE:RE:RE:RE:RE:RE:Aside from share price ... smells right for some bolt-ons

RE:RE:RE:RE:RE:RE:RE:Aside from share price ... smells right for some bolt-onsThis is the last thing I'll say for a while..

Any time I've heard of investors speak of Knight in the last couple of years, they mentioned that the company has gone nowhere for the last 8 years. Management was over-hyped. Raised too much cash, etc. and they are so glad they sold. All of that has been true or true to some extent. 

However...GUD is completely different today than it was in 2014-2019.

At that time, it was cash, a couple of drugs and a PRV and an experienced management team. There was no foundation to build off of, no momentum, no where to put the cash to use in a zero interest rate environment. Today's Knight is a very different beast and yet so many investors are blinded by the past.

A few are starting to see the recent changes as a positive, as I believe they should and building their positions such as Armoyan. The rest will follow suit once it's crystal clear.


<< Previous
Bullboard Posts
Next >>